On January 12, 2023, an extraordinary general meeting was held in SynAct Pharma AB (publ). All resolutions were adopted with the required majority of votes.
Extraordinary General Meeting January 2023
Documents
-
Minutes from extraordinary general meetingpdfJanuary 12, 2023 English
-
Bulletin from the extraordinary general meeting of SynAct Pharma ABpdfJanuary 12, 2023 English
-
Notice of extraordinary general meeting January 12, 2023pdfDecember 12, 2022 English
-
Power of AttorneypdfEnglish
-
Annual report of 2021 with a note on distribution of profitpdfEnglish
-
Proposal for resolution on (A) approval of acquisition of TXP Pharma AG (related party transaction); and (B) issue of new shares in kindpdfEnglish
-
Proposal for resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrantspdfEnglish
-
The board’s report on material events pursuant to Chap. 13 Sec. 6 of the Swedish Companies ActpdfEnglish
-
The board’s report on assets to be contributed in kind pursuant to Chap. 13 Sec. 7 of the Swedish Companies ActpdfEnglish
-
The board’s report on material events pursuant to Chap. 13 Sec. 6 and Chap. 14 Sec. 8 of the Swedish Companies ActpdfEnglish
-
Auditor’s statement pursuant to Chap. 13 Sec. 6 of the Swedish Companies ActpdfEnglish
-
Auditor’s statement pursuant to Chap. 13 Sec. 8 of the Swedish Companies ActpdfEnglish
-
Auditor’s statement pursuant to Chapter 13 Sec. 6 and Chap. 14 Sec. 8 of the Swedish Companies ActpdfEnglish
-
Fairness letter TXP transaction E&YpdfEnglish